223 related articles for article (PubMed ID: 30676070)
1. Macrophage-Derived Legumain Promotes Pulmonary Hypertension by Activating the MMP (Matrix Metalloproteinase)-2/TGF (Transforming Growth Factor)-β1 Signaling.
Bai P; Lyu L; Yu T; Zuo C; Fu J; He Y; Wan Q; Wan N; Jia D; Lyu A
Arterioscler Thromb Vasc Biol; 2019 Apr; 39(4):e130-e145. PubMed ID: 30676070
[TBL] [Abstract][Full Text] [Related]
2. Legumain promotes fibrogenesis in chronic pancreatitis via activation of transforming growth factor β1.
Ren YC; Zhao Q; He Y; Li B; Wu Z; Dai J; Wen L; Wang X; Hu G
J Mol Med (Berl); 2020 Jun; 98(6):863-874. PubMed ID: 32415356
[TBL] [Abstract][Full Text] [Related]
3. Caspase-8 Promotes Pulmonary Hypertension by Activating Macrophage-Associated Inflammation and IL-1β (Interleukin 1β) Production.
Rong W; Liu C; Li X; Wan N; Wei L; Zhu W; Bai P; Li M; Ou Y; Li F; Wang L; Wu X; Liu J; Xing M; Zhao X; Liu H; Zhang H; Lyu A
Arterioscler Thromb Vasc Biol; 2022 May; 42(5):613-631. PubMed ID: 35387479
[TBL] [Abstract][Full Text] [Related]
4. EP3 receptor deficiency attenuates pulmonary hypertension through suppression of Rho/TGF-β1 signaling.
Lu A; Zuo C; He Y; Chen G; Piao L; Zhang J; Xiao B; Shen Y; Tang J; Kong D; Alberti S; Chen D; Zuo S; Zhang Q; Yan S; Fei X; Yuan F; Zhou B; Duan S; Yu Y; Lazarus M; Su Y; Breyer RM; Funk CD; Yu Y
J Clin Invest; 2015 Mar; 125(3):1228-42. PubMed ID: 25664856
[TBL] [Abstract][Full Text] [Related]
5. RAGE-mediated extracellular matrix proteins accumulation exacerbates HySu-induced pulmonary hypertension.
Jia D; He Y; Zhu Q; Liu H; Zuo C; Chen G; Yu Y; Lu A
Cardiovasc Res; 2017 May; 113(6):586-597. PubMed ID: 28407046
[TBL] [Abstract][Full Text] [Related]
6. Platelet-Derived TGF (Transforming Growth Factor)-β1 Enhances the Aerobic Glycolysis of Pulmonary Arterial Smooth Muscle Cells by PKM2 (Pyruvate Kinase Muscle Isoform 2) Upregulation.
Zhu Y; Shu D; Gong X; Lu M; Feng Q; Zeng XB; Zhang H; Gao J; Guo YW; Liu L; Ma R; Zhu L; Hu Q; Ming ZY
Hypertension; 2022 May; 79(5):932-945. PubMed ID: 35232222
[TBL] [Abstract][Full Text] [Related]
7. Osteoprotegerin Disruption Attenuates HySu-Induced Pulmonary Hypertension Through Integrin αvβ3/FAK/AKT Pathway Suppression.
Jia D; Zhu Q; Liu H; Zuo C; He Y; Chen G; Lu A
Circ Cardiovasc Genet; 2017 Feb; 10(1):. PubMed ID: 28077433
[TBL] [Abstract][Full Text] [Related]
8. A Selective Transforming Growth Factor-β Ligand Trap Attenuates Pulmonary Hypertension.
Yung LM; Nikolic I; Paskin-Flerlage SD; Pearsall RS; Kumar R; Yu PB
Am J Respir Crit Care Med; 2016 Nov; 194(9):1140-1151. PubMed ID: 27115515
[TBL] [Abstract][Full Text] [Related]
9. Serum-glucocorticoid regulated kinase 1 regulates macrophage recruitment and activation contributing to monocrotaline-induced pulmonary arterial hypertension.
Xi X; Liu S; Shi H; Yang M; Qi Y; Wang J; Du J
Cardiovasc Toxicol; 2014 Dec; 14(4):368-78. PubMed ID: 24825325
[TBL] [Abstract][Full Text] [Related]
10. Interleukin-10 expression mediated by an adeno-associated virus vector prevents monocrotaline-induced pulmonary arterial hypertension in rats.
Ito T; Okada T; Miyashita H; Nomoto T; Nonaka-Sarukawa M; Uchibori R; Maeda Y; Urabe M; Mizukami H; Kume A; Takahashi M; Ikeda U; Shimada K; Ozawa K
Circ Res; 2007 Sep; 101(7):734-41. PubMed ID: 17673672
[TBL] [Abstract][Full Text] [Related]
11. CTRP9 regulates hypoxia-mediated human pulmonary artery smooth muscle cell proliferation, apoptosis and migration via TGF-β1/ERK1/2 signaling pathway.
Li YX; Run L; Shi T; Zhang YJ
Biochem Biophys Res Commun; 2017 Sep; 490(4):1319-1325. PubMed ID: 28688765
[TBL] [Abstract][Full Text] [Related]
12. Activin-like kinase 5 (ALK5) mediates abnormal proliferation of vascular smooth muscle cells from patients with familial pulmonary arterial hypertension and is involved in the progression of experimental pulmonary arterial hypertension induced by monocrotaline.
Thomas M; Docx C; Holmes AM; Beach S; Duggan N; England K; Leblanc C; Lebret C; Schindler F; Raza F; Walker C; Crosby A; Davies RJ; Morrell NW; Budd DC
Am J Pathol; 2009 Feb; 174(2):380-9. PubMed ID: 19116361
[TBL] [Abstract][Full Text] [Related]
13. Combined effects of the ATP-sensitive potassium channel opener pinacidil and simvastatin on pulmonary vascular remodeling in rats with monocrotaline-induced pulmonary arterial hypertension.
Jiang L; Zhou T; Liu H
Pharmazie; 2012 Jun; 67(6):547-52. PubMed ID: 22822545
[TBL] [Abstract][Full Text] [Related]
14. Galectin-3 mediates pulmonary vascular remodeling in hypoxia-induced pulmonary arterial hypertension.
Luo H; Liu B; Zhao L; He J; Li T; Zha L; Li X; Qi Q; Liu Y; Yu Z
J Am Soc Hypertens; 2017 Oct; 11(10):673-683.e3. PubMed ID: 28826890
[TBL] [Abstract][Full Text] [Related]
15. Transgenic expression of human matrix metalloproteinase-9 augments monocrotaline-induced pulmonary arterial hypertension in mice.
George J; D'Armiento J
J Hypertens; 2011 Feb; 29(2):299-308. PubMed ID: 21063214
[TBL] [Abstract][Full Text] [Related]
16. Injury-Induced Shedding of Extracellular Vesicles Depletes Endothelial Cells of Cav-1 (Caveolin-1) and Enables TGF-β (Transforming Growth Factor-β)-Dependent Pulmonary Arterial Hypertension.
Oliveira SDS; Chen J; Castellon M; Mao M; Raj JU; Comhair S; Erzurum S; Silva CLM; Machado RF; Bonini MG; Minshall RD
Arterioscler Thromb Vasc Biol; 2019 Jun; 39(6):1191-1202. PubMed ID: 30943774
[TBL] [Abstract][Full Text] [Related]
17. Matrix metalloproteinase 2 activation of transforming growth factor-beta1 (TGF-beta1) and TGF-beta1-type II receptor signaling within the aged arterial wall.
Wang M; Zhao D; Spinetti G; Zhang J; Jiang LQ; Pintus G; Monticone R; Lakatta EG
Arterioscler Thromb Vasc Biol; 2006 Jul; 26(7):1503-9. PubMed ID: 16690877
[TBL] [Abstract][Full Text] [Related]
18. SGK1 Mediates Hypoxic Pulmonary Hypertension through Promoting Macrophage Infiltration and Activation.
Xi X; Zhang J; Wang J; Chen Y; Zhang W; Zhang X; Du J; Zhu G
Anal Cell Pathol (Amst); 2019; 2019():3013765. PubMed ID: 31815093
[TBL] [Abstract][Full Text] [Related]
19. NMDA-Type Glutamate Receptor Activation Promotes Vascular Remodeling and Pulmonary Arterial Hypertension.
Dumas SJ; Bru-Mercier G; Courboulin A; Quatredeniers M; Rücker-Martin C; Antigny F; Nakhleh MK; Ranchoux B; Gouadon E; Vinhas MC; Vocelle M; Raymond N; Dorfmüller P; Fadel E; Perros F; Humbert M; Cohen-Kaminsky S
Circulation; 2018 May; 137(22):2371-2389. PubMed ID: 29444988
[TBL] [Abstract][Full Text] [Related]
20. Schisandrin B displays a protective role against primary pulmonary hypertension by targeting transforming growth factor β1.
Wu J; Jia J; Liu L; Yang F; Fan Y; Zhang S; Yan D; Bu R; Li G; Gao Y; Chen Y
J Am Soc Hypertens; 2017 Mar; 11(3):148-157.e1. PubMed ID: 28117274
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
